Studies indicate the ability of this medicine to encourage the creation of new blood vessels, boost collagen generation, and facilitate fibroblast migration to the injury location
It remains under clinical investigation and has not yet received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
Others prefer morning injections so they can monitor for any reactions during waking hours
Materials and methods: This study was possible due to the collaboration across multiple clinical and academic research centres including in Australia, Canada, Denmark, Hong Kong, India, New Zealand and the USA
Never use visibly altered medicationcontact your pharmacy immediately for a replacement dose
**Not all patients are a candidate for every treatment